BioCentury | Jan 20, 2021
Product Development
Trucode reboots as Vera with Abingworth-led $80M series C, disease-modifying therapy for orphan kidney disease
...TNF superfamily member 13b
Danielle Golovin
Abingworth LLP
Trucode Gene Repair Inc.
ZymoGenetics Inc.
Merck KGaA
Bristol-Myers Squibb Co.
Kleiner Perkins
GV
Sofinnova Investments
Longitude Capital
Fidelity Management and Research Company
Surveyor...